folder Filed in Funding daily
Walking Fish Therapeutics closed a $50 million Series A financing
By Tsani Gramatikova access_time 1 min read

What is Walking Fish Therapeutics?

Walking Fish Therapeutics is a broad B cell platform for oncology, regenerative medicine, autoimmune disease, and recombinant antibody production.

What does Walking Fish Therapeutics do?

The company has developed a platform to harness B cells’ capability to activate the immune system.

Who owns Walking Fish Therapeutics?

Lewis (Rusty) Williams and Mark Selby founded the company in San Francisco Bay Area under the legal name Walking Fish Therapeutics, Inc.

How much has Walking Fish Therapeutics raised?

Walking Fish Therapeutics raised $50M in a Series A funding round.

Who has invested in Walking Fish Therapeutics?

 Emerson Collective and Illumina Ventures led the latest funding round.

What domain name does Walking Fish Therapeutics operate on?

Walking Fish Therapeutics is operating on the domain name.

Related reads

How to name your business

8 Mistakes entrepreneurs make when buying domain names upgrade to

branding business domain domain name domains